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1. Module title: «Current practice of internal medicine». 
2. Theme title: «Management the patient with a heart murmur». 
3. Theme specifications.  
4. Theme aims.  
The aim of this module is to provide the student with an opportunity to 
keeping patient in cardiology clinic. 
 
5. Learning outcomes 
Student must know causes of heart murmurs.  Etiology, pathogenesis. 
Haemodynamics. Clinical finding, treatment. Surgical treatment the Heart valve 
disease. 
Students should be able  
1. To execute assessment, diagnosis and management the patient with a 
heart murmur.  
2. To obtain the skills of interpretation of Doppler echocardioscopy. 
3. To obtain the skills of interpretation of the results of stress tests. 
4. To obtain the skills of interpretation of electrocardiograms. 
 
6. TESTS AND ASSIGNMENTS FOR SELF-ASSESSMENT 
BASIC LEVEL OF KNOWLEDGE: MULTIPLE CHOICE QUESTIONS 
(CHOOSE THE CORRECT ANSWER/STATEMENT) 
 
1. A female rheumatic patient experiences diastolic thoracic wall tremor 
(diastolic thrill), accentuated S1 at apex, there is diastolic murmur with presystolic 
intensification, opening snap, S2 accent at pulmonary artery. What kind of heart 
disorder is observed? 
A. Aortic valve insufficiency.  
B. Mitral stenosis.  
C. Mitral valve insufficiency. 
D. Opened arterial duct. 
E. Pulmonary artery stenosis. 
 
 
2. All of the following clinical findings are consistent with severe mitral 
stenosis except 
A. Atrial fibrillation. 
B. Opening snap late after S2. 
C. Pulmonary vascular congestion 
D. Pulsatile liver. 
E. Right-ventricular heave. 
 
 
3. The most frequent type of valvular heart disease in the elderly is: 
A. Pulmonary stenosis. 
B. Mitral stenosis. 
C. Mitral regurgitation. 
D. Aortic stenosis. 
E. Aortic regurgitation. 
 
 
 
 4 
4. After objective clinical examination a 18 year old male was diagnosed 
with mitral valve prolapse. What complementary instrumental  method of ex-
amination should be applied for the diagnosis confirmation?   
A. Phonocardiograph.    
B. ECG.    
C. Roentgenography of chest..   
D. Echocardiography.    
E. Veloergometry.    
 
   
5. A 42 y.o. woman complains of dyspnea, edema of the legs, and tachycardia 
during small physical exertion. Heart borders are displaced to the left and SI is 
accentuated, there is diastolic murmur on apex. The liver is enlarged by 5 cm. What 
is the cause of heart failure? 
A. Mitral stenosis. 
B. Tricuspid stenosis. 
C. Aortic stenosis. 
D. Mitral regurgitation. 
E. Tricuspid regurgitation. 
 
 
7. Specification of the theoretical question for training of   
«Management the patient with a heart murmur» 
 
1. Mitral stenosis. Etiology, pathogenesis. Hemodynamics. Clinical 
finding, treatment. Surgical treatment. 
2. Mitral regurgitation. Etiology, pathogenesis. Hemodynamics. Clinical 
finding, treatment. Surgical treatment. 
3. Aortic valve stenosis. Etiology, pathogenesis. Hemodynamics. Clini-
cal finding, treatment. Surgical treatment. 
4. Aortic insufficiency. Etiology, pathogenesis. Hemodynamics. Clini-
cal finding, treatment. Surgical treatment. 
5. Tricuspid regurgitation. Etiology, pathogenesis. Hemodynamics. 
Clinical finding, treatment. Surgical treatment. 
6. Tricuspid stenosis. Etiology, pathogenesis. Hemodynamics. Clinical 
finding, treatment. Surgical treatment. 
7. Indicative syllabus. 
 
The patient with a heart murmur 
Genesis and types of heart murmurs 
 
Murmurs are defined as sounds heard in addition to the sequence of two 
to three heart sounds during each heartbeat. The two normal heart sounds–the 
first heart sound (S1) and the second heart sound (S2)—are produced mainly by 
the closure of the atrioventricular (tricuspid and mitral) and semilunar (aortic 
and pulmonary) valves, respectively. Occasionally, an additional heart sound 
associated with the ventricles filling up with blood may be heard. It is referred 
to as S3 when it occurs in early diastole and S4 when heard in late diastole after 
the atrial contraction. 
 5 
Heart murmurs can be systolic, diastolic or continuous and they can be 
reported with accompanying intensity grades. When clinically insignificant, 
murmurs are referred to as being "innocent"; they are caused by increased flow or 
turbulence across anatomically normal valves. Some systolic murmurs may be 
clinically innocent, while all diastolic and continuous murmurs are abnormal. 
Causes 
Innocent Heart Murmurs. Innocent murmurs are heard when 
blood moves noisily through a normal heart. Sometimes these murmurs 
occur when:  
 Blood is flowing faster than usual through the heart and blood vessels 
attached to it.  
 An increased amount of blood is flowing through the heart.  
Illnesses or conditions that can cause blood to flow to be faster than 
usual through the heart include:  
 Fever  
 Anemia  
 Hyperthyroidism  
 Pregnancy. 
Congenital heart murmurs. Congenital heart murmurs are heard in the 
newborn. They may be due to abnormalities in the valves, septae or arteries, 
and veins that carry blood to and from the heart. In some complicated heart 
disease conditions there may be a combination of all three. Many congenital 
heart murmurs resolve spontaneously without medical intervention while others 
require surgical operations for repair. 
Common congenital heart defects include the following: 
 Atrial septal defect (ASD) is a hole in the septum (wall) that divides 
the heart's upper chambers (atria). 
 Ventricular septal defect (VSD) is a hole in the septum that divides 
the heart's lower chambers (ventricles). More than half of all abnormal heart 
murmurs in children are caused by ventricular septal defects. 
 Patent ductus arteriosus (PDA) occurs when the ductus arteriosus 
does not close after birth. A developing fetus does not breathe while in the 
uterus; therefore, its lungs do not require a blood supply. Before birth, a chan-
nel called the ductus arteriosus diverts blood around the lungs by connecting 
the pulmonary arteries, which supply blood to the lungs after birth, to the aorta, 
which supplies blood to the rest of the body. After birth, when the infant is 
breathing and the lungs fill with air, the ductus arteriosus normally closes, al-
lowing blood to flow through the pulmonary arteries to the lungs. In a baby 
with PDA, the channel stays open and blood continues to pass by the lungs. 
 Cardiomyopathy causes the heart muscle to become too thick or too 
weak to pump blood normally.  
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 Stenosis occurs when heart valves are "sticky" or too narrow, affecting 
blood flow into or out of the heart. 
 Regurgitation occurs when heart valves do not close completely and 
blood leaks backward into the heart. 
In cyanotic lesions, a portion of nonoxygenated blood never reaches the 
lungs; instead, it is shunted to the systemic circulation. Examples include trans-
position of great arteries, tetralogy of Fallot and single ventricle. Certain people 
with congenital heart disease have a characteristic body habitus, such as pa-
tients with trisomy 21 (Down syndrome). They have an increased prevalence of 
atrial or ventricular septal defects and tetralogy of Fallot. 
Furthermore, congenital heart disease is associated with heritable con-
nective tissue disorders such as osteogenesis imperfecta, Ehlers-Danlos syn-
drome, Marfan syndrome  and Stickler’s syndrome.  
In adults and older children, heart murmurs are typically caused by 
heart valve problems related to infections, illness, or aging. These conditions 
include the following: 
 Rheumatic fever is an inflammatory illness that can develop when 
strep throat infection is not properly treated. Rheumatic fever may eventually 
damage heart valves permanently. 
 Endocarditis is a bacterial infection that attacks the inner lining of the 
heart. Left untreated, it can damage or destroy heart valves, block blood flow, 
or cause blood to leak backward. 
 Mitral valve prolapse occurs when the mitral valve does not close 
properly. The mitral valve is located between the left atrium and left ventricle. 
When this valve doesn't close as it should, the "leaflets" of the valve expand 
back into the atrium when the left ventricle contracts. Mitral valve prolapse 
sometimes is a congenital heart defect that is not discovered until adulthood. 
Valve calcification may develop as people age. In this condition, the 
heart valves harden or thicken, making it more difficult for blood to move 
through them. 
 Cardiac myxoma, which is the most common type of heart tumor in 
adults, can grow inside of the heart and block blood flow. 
 Hypertrophic cardiomyopathy (also called idiopathic hypertrophic 
subaortic stenosis) is a condition that causes the muscle inside the left ventricle 
to thicken, narrowing the path for blood flow. 
Worldwide, the most common cause of clinically significant heart 
murmurs is rheumatic heart disease (RHD). In the United States and Can-
ada, however, RHD is an uncommon finding except among recent immi-
grants. The most common causes of clinically significant  murmurs in this 
country are degenerative valvular disorders such as senile calcific aortic 
stenosis (AS) and mitral valve prolapse (MVP). Less common causes of 
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acquired valvular disease are systemic lupus erythematosus (SLE)  and cer-
tain medications used in weight loss programs. 
Rheumatic heart disease. RHD is triggered by group A streptococcal 
pharyngitis. The microorganism induces an autoimmune reaction that may lead 
to valvular scarring and calcifications, especially involving the mitral valve. 
The most common forms of RHD are mitral stenosis and aortic insufficiency, 
both of which produce diastolic murmurs.  
Aortic stenosis. Owing to aging, an initially normal trileaflet aortic 
valve may undergo calcific degeneration. Subsequent narrowing of the aortic 
valve orifice results in the clinical manifestations of AS in the elderly.  When 
calcific aortic stenosis is encountered in middle-aged people, the clinician 
should suspect a diagnosis of congenitally bicuspid aortic valve (BAV). BAV is 
the most common form of congenital heart disease, occurring in 1 to 2 percent 
of all live births.  
Mitral valve prolapse. Myxomatous degeneration of valve leaflets, 
typically those of the mitral valve, results in leaflet redundancy and systolic 
billowing of one or both leaflets into the left atrium. Sometimes, this is accom-
panied by regurgitation. Although the prognosis for MVP is good in general, it 
is the valvular disease that necessitates the most valve surgery in the United 
States. In cases in which MVP is associated with regurgitation, a murmur often 
will be heard preceded by a systolic click.  Antibiotic prophylaxis is warranted 
for patients with MVP only when mitral regurgitation is present . 
Systemic lupus erythematosus. Verrucous valvular lesions in SLE can 
be found in up to 60 percent of affected patients. Libman-Sacks endocarditis in 
patients with SLE refers to valvular thickening, followed by vegetations (that is, 
thrombi adherent to a diseased valve and composed of platelets, fibrin and 
sometimes microorganisms) and valvular insufficiency. Initially, the damage is 
caused by immune complex deposition on the valve. Patients with SLE who 
have Libman-Sacks endocarditis are at moderate risk of developing IE. 
According to the guidelines of the American College of Cardiolo-
gists/American Heart Association, these patients should receive prophylactic 
antibiotics 
Endocrine conditions. Patients with active or treated acromegaly have a 
high prevalence of mitral and aortic valve abnormalities characterized by fibro-
sis and/or calcifications of valve annulus and leaflets, which may lead to valvu-
lar regurgitation or stenosis.  
All of the above-mentioned forms of acquired valvular disease confer a 
moderate risk of developing IE after dental procedures. Some forms of acquired 
valvular disease, however, carry a much higher risk. These include a history of 
IE and valve surgery . 
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DETECTION OF A HEART MURMUR 
 
There are several ways  may describe a murmur: 
 Murmurs are classified ("graded") depending on how loud the murmur 
sounds with a stethoscope. The grading is on a scale. Grade I can barely be 
heard. An example of a murmur description is a "grade II/VI murmur." (This 
means the murmur is grade 2 on a scale of 1-6). 
 Murmurs may be described as blowing, whooshing, or rasping. 
 In addition, a murmur is described by the stage of the heartbeat when 
the murmur is heard. A heart murmur may be described as systolic or diastolic.  
The following are important clues to the cause of the murmur: 
 Does the murmur occur in the resting stage (diastole) or contracting 
stage (systole)? 
 Does it occur early or late in the stage? 
 Does it last throughout the heartbeat? 
 Does it change when the doctor uses physical maneuvers? 
 Can the murmur be heard in other parts of the chest, on the back, or in 
the neck? 
 Where is the murmur heard the loudest? 
Auscultation. The most common abnormal auscultatory finding on car-
diac examination is a systolic murmur, which occurs in 80 to 96 percent of 
children and in 15 to 44 percent of adults.These murmurs can be functional 
(innocent) or pathological.  
The current American College of Cardiologists/American Heart Asso-
ciation guidelines for the treatment of patients with valvular heart disease state 
that cardiac auscultation remains the most widely used technique of screening 
for heart disease, and that a careful observer will be able to deduce the correct 
origin and significance of a heart murmur. The physician should use echocardi-
ography to confirm an impression or diagnosis of structural heart disease.  
Echocardiography. Echocardiography is a diagnostic test that uses 
ultrasound waves to make images of the heart chambers, valves and sur-
rounding structures. The purpose of echocardiography with regard to heart  
murmurs is to evaluate the primary lesion in terms of cause and severity, 
define the lesion’s hemodynamic significance,  detect coexisting abnormali-
ties, evaluate the size and function  of cardiac chambers and establish a ref-
erence point for future comparisons.  
The standard echocardiography is called transthoracic echocardiography 
(TTE). In this procedure, the clinician performs cardiac imaging after placing an 
ultrasound probe on various points on the external chest and abdominal walls.  
During transesophageal echocardiography (TEE), the heart and large 
vessels are imaged after a small ultrasound probe is introduced into the esopha-
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gus and stomach. It is considered an invasive procedure and should be used 
only when information beyond that obtained from conventional TTE is needed.  
Overall, TTE has a lower sensitivity (60 to 70 percent) than does TEE 
(75 to 95 percent) in detecting infective endocarditis, particularly that of left-
sided (mitral and aortic) valves. However, for the detection of infective endo-
carditis of the tricuspid valve, TTE often is as sensitive as TEE.  
Both TTE and TEE are capable of M-mode, two-dimensional and Dop-
pler imaging. Once echocardiographic images are acquired and stored on a 
videotape or computer disk, the cardiologist analyzes the examination findings 
and writes a report. The major components of this report are discussed below. 
In view of the current literature, echocardiography is the procedure of 
choice for evaluating a heart murmur, but this technology should not be used as 
a "fishing net." Echocardiography probably is not a cost-effective method of 
screening asymptomatic patients for valvular heart disease. It should be re-
served for dental patients with a moderate-to-severe risk of developing IE. 
When the clinician suspects IE, a positive echocardiographic finding is one of 
several major Duke criteria for the establishment of an IE diagnosis 
Echocardiographic report. The echocardiographic report has many 
components. The normal values may vary from one medical center to another, but 
the various components of a standard report are similar. As with all laboratory 
reports, the initial review should make sure that the patient’s name on the report is 
correct. The date and type of study (TTE or TEE) follow, along with general 
information about the patient (for example, age, sex, location of care).  
The information regarding chamber sizes and wall thickness often is ob-
tained via M-mode echocardiography. A descriptive section of the report fol-
lows the numeric data in which specific cardiac pathology (if present) is men-
tioned, and its hemodynamic significance is discussed based on the data from 
all echocardiographic imaging modalities.  
One of the most important parameters of cardiac function is the left 
ventricular ejection function. An ejection fraction below 50 percent sug-
gests left ventricular systolic dysfunction (that is, decreased left ventricular 
contractility).  
 
GENERAL MEDICAL TREATMENT OF PATIENTS  
WITH MURMURS 
 
The clinician’s approach to treating patients with heart murmurs de-
pends on many variables, including the characteristics of the murmur itself 
(such as the intensity and type of murmur) and the presence or absence of 
cardiac symptoms.  
For example, an extensive work-up is not necessary for patients with 
grade 1 and 2 midsystolic murmurs if they are children or young adults in 
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whom the cardiac examination results are normal, and who do not have other 
signs and symptoms associated with cardiac disease.  
However, if patients have signs and symptoms indicating the presence 
of IE, thromboembolism, congestive heart failure, myocardial infarction or 
syncope, echocardiography is indicated.  
The classic symptoms of cardiac disease include chest pain or chest 
discomfort, dyspnea, palpitations and syncope. In the review of systems, clini-
cians must ask these key questions, the answers to which will give them clues 
regarding whether the murmur is innocent or clinically significant.  
As noted above, mild regurgitation of the mitral, tricuspid or pulmonic 
valves frequently is detected in asymptomatic patients, often in the absence of 
an audible murmur on auscultation. In principle, such patients do not require 
routine antibiotic prophylaxis before dental and other bacteremia-inducing 
medical procedures. 
In the work-up of a patient with a pathological heart murmur, echocar-
diography is mandatory to confirm the diagnosis, establish the severity of the 
lesion and assess ventricular function and size.  
All health professionals, including dental professionals, should educate their 
patients who have clinically significant heart murmurs about antibiotic prophylaxis, 
while cardiologists and other physicians should counsel patients about functional 
limitation, exercise and work restrictions, and pregnancy issues.  
Mitral stenosis 
Mitral stenosis (MS) is a narrowing of the inlet valve into the left ven-
tricle that prevents proper opening during diastolic filling. Patients with mitral 
stenosis typically have mitral valve leaflets that are thickened, commissures 
that are fused, and/or chordae tendineae that are thickened and shortened 
The normal mitral valve area is 4.0 to 5.0 cm2. Narrowing of the valve 
area to <2.5 cm2 must occur before development of symptoms.  
A mitral valve area >1.5 cm2 usually does not produce symptoms at rest. 
However, if there is an increase in transmitral flow or a decrease in the diastolic 
filling period, there will be a rise in left atrial pressure and development of 
symptoms. Thus, the first symptoms of dyspnea in patients with mild MS are 
usually precipitated by exercise, emotional stress, infection, pregnancy, or atrial 
fibrillation with a rapid ventricular response. 
Etiology. Chronic rheumatic heart disease is much the commonest 
cause of mitral stenosis, though there are a number of other well defined condi-
tions in which blood flow across the mitral valve is limited to a variable extent. 
1. Congenital mitral stenosis is a rare condition with thick, rolled leaflets 
and short chordae, with the spaces between them obliterated. The papillary mus-
cles may be abnormally inserted, either directly from the free wall of the ventricle 
or from the septum. In parachute mitral valve, there is only one papillary muscle. 
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Congenital mitral stenosis may be associated with left ventricular outflow ob-
struction, hypoplasia of the left ventricular cavity and the aorta, or endocardial 
fibroelastosis. 
2. A calcified mitral valve ring may rarely cause mild mitral stenosis. 
3. In infective endocarditis, bulky vegetations may occasionally inter-
fere with transmitral flow. 
4. Nodular rheumatoid arthritis may be associated with thickening of the 
valve cusps, but true mitral stenosis does not occur. 
5. In systemic lupus erythematosus, treatment of Libman–Sachs endo-
carditis with steroids has led to fibrosis of the cusps with commissural fusion. 
6. The combination of ostium secundum atrial septal defect and rheu-
matic mitral stenosis, Lutembacher syndrome, is probably fortuitous. 
Rheumatic mitral stenosis 
Incidence. The incidence of rheumatic mitral stenosis parallels that of 
acute rheumatic fever. It is thus much commoner, and presents earlier, in the 
Middle East, the Indian sub-continent, and the Far East than in the West. 
Clinical features 
History. Inquire about the history of acute rheumatic fever (RF), al-
though 50-60% of patients do not recall this. Also inquire about history of re-
peated streptococcal pharyngitis or scarlet fever in childhood. 
Many patients are asymptomatic. Some patients may develop. 
 Symptoms during physiologic stress such as infection, exercise, fever, 
or pregnancy. 
 Exertional dyspnea, orthopnea, and paroxysmal nocturnal dyspnea 
(symptoms of left heart failure) are most common. Dyspnea may be accompa-
nied by cough and wheezing. Attacks of frank pulmonary edema may occur. 
 Chest pain due to right ventricular ischemia, concomitant coronary 
atherosclerosis, or a coronary embolism may be present. 
 Hemoptysis from pulmonary venous hypertension results in rupture of 
anastomosis between bronchial veins. 
 Ortner syndrome may occur if an enlarged left atrium impinges on the 
left recurrent laryngeal nerve, causing hoarseness. 
 Patients may present with complications of mitral stenosis.   
 New-onset atrial fibrillation. 
 Systemic embolism. 
 Infective endocarditis. 
Physical. Look for findings not only intrinsic to valvular deformity but 
also hemodynamic disturbance from the stenotic valve and its complications. 
Symptoms 
 Cardiac examination of stenotic mitral valve (best at the apex with the 
patient in the left lateral recumbent position).  
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 Palpable diastolic thrill 
 An accentuated S1, followed by S2, and an opening snap (OS) 
 Characteristic diastolic low-pitched, rumbling murmur 
 The duration, and not intensity, of the murmur is a guide to the se-
verity of mitral valve narrowing. However, murmur may diminish in intensity 
as the stenosis increases. 
 The OS and diastolic murmur are often reduced during inspiration 
and augmented during expiration. Amyl nitrite inhalation, coughing, isometric 
or isotonic exercise, and sudden squatting all are useful in accentuating a faint 
or equivocal murmur of mitral stenosis. 
 Signs of left heart failure.  
 Respiratory distress, evidence of pulmonary edema (eg, rales) 
 Digital clubbing. 
 Signs of right heart strain/failure.  
 Right ventricular lift may be felt. A loud pulmonic closure (P2) 
may be noted in the left parasternal region in patients with pulmonary hy-
pertension. 
 Jugular venous distention, ascites, hepatomegaly, and peripheral 
edema may be noted. 
 Auscultation may reveal a systolic murmur of TR, a Graham Steele 
murmur of PR (a high-pitched, decrescendo, diastolic murmur of pulmonary 
insufficiency), and an S4. 
 Signs of complications from mitral stenosis.  
 Endocarditis - Fever, murmur, and classically splinter hemorrhage, 
petechiae, Roth spots, Osler nodes, or Janeway lesions. 
 Atrial fibrillation 
 Systemic embolization 
 Other findings.  
 A holosystolic murmur of mitral regurgitation may accompany the 
valvular deformity of mitral stenosis. 
 "Mitral facies" characterized by pinkish purple patches on the 
cheeks may be present. 
Investigations 
Chest radiography 
 Look for left atrial, pulmonary artery, right ventricle, and/or right atrium 
enlargement (eg, straightening of left heart border, loss of aortic window). 
 Rarely, calcification of the mitral valve may be seen. 
 Radiologic changes in the lung fields indirectly reflect the severity of 
mitral stenosis. 
 Interstitial edema manifests as Kerley B lines. 
 13 
 Severe, long-standing mitral obstruction results in Kerley A lines and 
findings of pulmonary hemosiderosis. 
 Pulmonary edema is seldom evident on the chest radiography. 
Echocardiography 
 Two-dimensional (2D) and Doppler echocardiography (echo) is the di-
agnostic study of choice. It should be performed in order to make the diagnosis 
and to assess valve function whenever a change in symptoms or physical ex-
amination findings is noted.  
 2D echocardiography evaluates the morphology of the mitral valve, 
measuring orifice size and detailing leaflet mobility, thickness, calcification, 
fusion, and appearance of the commissures. It provides anatomic and functional 
information on cardiac chambers and facilitates recognition of other structural 
abnormalities. 
 Doppler echocardiography is the most accurate noninvasive tech-
nique to quantify the hemodynamic severity of mitral stenosis at rest or with 
exercise. It measures transvalvular pressure gradient and pulmonary arterial 
pressure and determines whether mitral regurgitation, aortic regurgitation, and 
other valvular abnormalities coexist. 
 If a question exists about the diagnosis after transthoracic echocar-
diography, a transesophageal echocardiography (TEE) provides better images 
of the mitral valve and is a more sensitive way to detect pathology such as 
valvular vegetations or atrial thrombus. 
Cardiac catheterization. This is rarely necessary, either to make the 
diagnosis or to assess severity. It is performed only to determine the state of the 
coronary arteries in older patients and as a prelude to balloon valvuloplasty, or 
very occasionally in patients in whom diagnostic echocardiograms cannot be 
obtained 
Other Tests 
 ECG is relatively insensitive for mild mitral stenosis.  
 Ninety percent of patients with significant mitral stenosis and sinus 
rhythm display electrical evidence of left atrial enlargement: P-mitrale in lead II 
and/or a biphasic P wave in lead V1 with a wide negative deflection greater 
than 0.04 seconds. 
 The QRS axis in the frontal plane correlates with the severity of 
valve obstruction in pure mitral stenosis. A mean axis between 0 and +60 de-
grees suggests a mitral valve area >1.3 cm2, whereas an axis of more than 60 
degrees suggests a valve area <1.3 cm2. 
 Atrial fibrillation usually develops in the presence of preexisting 
left atrial enlargement. 
 With severe pulmonary hypertension, right-axis deviation and right 
ventricular hypertrophy can be seen. The ECG of right ventricular hypertrophy 
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typically shows tall R waves in the right chest leads, and the R wave may be 
taller than the S wave in lead V1. In addition, right-axis deviation and right 
precordial T-wave inversions are often present. 
 Exercise stress testing  
 Exercise stress testing is indicated in situations where the degree of 
disability is in question. 
 Stress echocardiography will provide information about changes in 
the transmitral gradient and the degree of limitation of exercise and may guide 
decisions about valvotomy. 
Laboratory Studies 
 Ruling out other diseases is useful. 
 Brain natriuretic peptide may be useful in determining the presence of 
heart failure in an undifferentiated patient with dyspnea. 
 Troponin I and creatinine kinase levels may be useful in ruling out 
acute myocardial infarction in patients who present with symptomatic mi-
tral stenosis. 
Diagnosis. The diagnosis of mitral stenosis is usually straightforward 
on the basis of history, physical signs, and chest radiography, and can rapidly 
be confirmed by echocardiography. When the ventricular rate is rapid, the dia-
stolic murmur may be inaudible, but becomes apparent when the ventricular 
rate is controlled by digoxin. Silent mitral stenosis may mimic primary pulmo-
nary hypertension, but the correct diagnosis is easily made by echocardiogra-
phy. Mild mitral stenosis should be suspected as a source of systemic emboli 
and as a cause of unexplained atrial fibrillation, particularly in the elderly. 
Differential diagnosis 
1. Left atrial myxoma  
2. cor triatriatum  
3. pulmonary veno-occlusive disease or 
4. Austin–Flint murmur  
Treatment 
Emergency Department Care. The goal is to control symptoms, to 
prevent or retard disease progression, and to treat complications. 
 Treatment of congestive heart failure  
 Medications to consider include nitroglycerin, ACE inhibitors, and diuretics. 
 Patients with severe mitral stenosis should maintain an upright pos-
ture and avoid strenuous physical activity. 
 Sodium intake should be restricted, and maintenance doses of oral 
diuretics should be continued. 
 The data on beta-blockers are conflicting; beta-blockade may be 
useful for patients with exertional symptoms if the symptoms occur primarily at 
high heart rates. 
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 Prevent or retard disease. Primary and/or secondary prophylaxis 
against streptococci/endocarditis should be administered.  
 Penicillin is indicated whenever streptococcal infection is sus-
pected in a patient with known rheumatic disease. 
 Management of atrial fibrillation  
 Much of the dyspnea related to mitral stenosis is rate related. Con-
trol of atrial fibrillation with rapid ventricular response may be considered with 
any of the following agents:  
 If the patient is unstable and immediate cardioversion is indicated 
(synchronized 100 J, 200 J, 300 J, then 360 J monophasic, or biphasic equiva-
lent, with prior sedation), then heparin should be administered before, during, 
and after cardioversion. Otherwise, electrical or chemical cardioversion should 
be performed after 3 weeks of warfarin anticoagulation. 
 Anticoagulation is necessary in patients who are unable to maintain 
normal sinus rhythm. 
 Anticoagulation may also be beneficial for patients with normal sinus 
rhythm with a prior embolic event or a left atrial dimension greater than 55 mm 
Hg noted by echocardiography. 
Consultations 
 Cardiologist and/or cardiac thoracic surgeon  
 Known or suspected cases of mitral stenosis with hemodynamic in-
stability, arrhythmia, or embolization. 
 Cases involving a new onset or progression of symptoms. 
Medication. The goal of medical therapy is to control the rapid ven-
tricular rate and to prevent thrombus formation and embolization. Conversion 
of atrial fibrillation to sinus rhythm may also decrease symptoms. 
Antiarrhythmics. These agents alter the electrophysiologic mecha-
nisms that are responsible for arrhythmia. 
 Amiodarone (Cordarone) 
Class III antiarrhythmic. Has antiarrhythmic effects that overlap all 4 
Vaughn-Williams antiarrhythmic classes. May inhibit AV conduction and sinus 
node function. Prolongs action potential and refractory period in myocardium 
and inhibits adrenergic stimulation. Only agent proven to reduce incidence and 
risk of cardiac sudden death, with or without obstruction to LV outflow. Very 
efficacious in converting atrial fibrillation and flutter to sinus rhythm and in 
suppressing recurrence of these arrhythmias. 
Has low risk of proarrhythmia effects, and any proarrhythmic reactions 
generally are delayed. Used in patients with structural heart disease. Most clini-
cians are comfortable with inpatient or outpatient loading with 400 mg PO tid 
for 1 wk because of low proarrhythmic effect, followed by weekly reductions 
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with goal of lowest dose with desired therapeutic benefit (usual maintenance 
dose for AF 200 mg/d). During loading, patients must be monitored for 
bradyarrhythmias. Prior to administration, control the ventricular rate and CHF 
(if present) with digoxin or calcium channel blockers. 
Oral efficacy may take weeks. With exception of disorders of prolonged 
repolarization (eg, LQTS), may be DOC for life-threatening ventricular ar-
rhythmias refractory to beta-blockade and initial therapy with other agents. 
Adult. 120 mg IV over 10 min follow by IV infusion Maintenance dos-
ing: 400 mg PO tid for 1-3 wk until desired effect achieved then followed by 
weekly reductions (goal of lowest dose with desired therapeutic benefit) 
Maintenance for AF: 200 mg/d PO 
 Digoxin (Lanoxin). Cardiac glycoside that has direct inotropic effects 
in addition to indirect effects on the cardiovascular system. Effects on myocar-
dium involve a direct action on the cardiac muscle that increases myocardial 
systolic contractions as well as indirect actions that result in increased carotid 
sinus nerve activity and enhanced sympathetic withdrawal for any given in-
crease in mean arterial pressure. 
Adult. 0.25 mg IV; up to 1 mg loading dose followed by a maintenance 
dose of 0.125-0.25 mg qd 
 Beta-adrenergic blockers. These drugs inhibit chronotropic, ino-
tropic, and vasodilatory responses to beta-adrenergic stimulation. 
Metoprolol (Lopressor) 
Selective beta1-adrenergic receptor blocker that decreases the auto-
maticity of contractions. During IV administration, carefully monitor blood 
pressure, heart rate, and ECG. 
Adult. 5 mg IV; repeat in 10 min; not to exceed 15 mg 
 Calcium channel blockers 
In specialized conducting and automatic cells in the heart, calcium is 
involved in the generation of the action potential. The calcium channel blockers 
inhibit movement of calcium ions across the cell membrane, depressing both 
impulse formation (automaticity) and conduction velocity. 
Diltiazem (Cardizem CD, Cardizem SR, Tiazac, Dilacor). During the 
depolarization, inhibits the calcium ion from entering the slow channels or the 
voltage-sensitive areas of the vascular smooth muscle and myocardium. 
Adult. 0.25 mg/kg IV over 2 min 
Rebolus after 15 min prn with 0.35 mg/kg IV 
 Anticoagulants. These agents inhibit thrombogenesis. 
Heparin. Augments activity of antithrombin III and prevents conver-
sion of fibrinogen to fibrin. Does not actively lyse but is able to inhibit further 
thrombogenesis. Prevents reaccumulation of clot after spontaneous fibrinolysis. 
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Most data are related to use of unfractionated heparin. Low molecular weight 
heparin probably is as effective but awaits the results from clinical studies. 
Adult. 80U/kg IV initially, followed by a maintenance infusion of 18 
U/kg/h IV; target aPTT is 50-70 s 
Warfarin (Coumadin). Inhibits vitamin K–dependent clotting factors 
II, VII, IX, and X and anticoagulant proteins C and S. Anticoagulation effect 
occurs 24 h after drug administration, but peak effect may happen 72-96 h later. 
Antidotes are vitamin K and FFP. 
Adult. 5-15 mg PO qd for 2-5 d, adjust to desired INR or PT; 2-10 mg/d 
PO qd maintenance Adjust dose to maintain INR of 2.5-3.5 or PT of 1.5-2 
times baseline 
 Further Inpatient Care 
 Balloon valvotomy is, in general, the initial procedure of choice for 
symptomatic patients with moderate-to-severe mitral stenosis. It can double the 
mean valve area with a 50-60% decrease in transmitral gradient, producing a 
prominent and sustained symptomatic improvement.  
 The 2006 ACC/AHA Practice Guidelines recommend percutaneous 
mitral balloon valvotomy for symptomatic patients (New York Heart Associa-
tion Functional Class, or NYHA FC, II, III, or IV) with moderate or severe 
mitral stenosis (mitral valve are  1.5 cm2), and favorable valve morphology in 
the absence of left atrial thrombus or significant mitral regurgitation.1 Signifi-
cant pulmonary artery hypertension (2/3 systolic blood pressure) is also an 
indication for intervention. 
 In patients with indications for intervention, it has proven superior 
to closed commissurotomy in some long-term studies. The overall event-free 
(from death, repeat valvotomy, or valve replacement) survival rate is 80-90% in 
patients with favorable valve morphology. More than 90% of patients free of 
events remain in NYHA FC I or II. In general, surgical commissurotomy, either 
open or closed, has 
 similar efficacy to balloon valvotomy. In the United States, open 
commissurotomy is considered the procedure of choice.  
 The 2006 ACC/AHA Practice Guidelines gave a class I recom-
mendation for surgical intervention in patients with NYHA FC III-IV symp-
toms, moderate or severe mitral stenosis, and valve morphology favorable for 
repair or replacement if one of the following exists:1  
 Percutaneous mitral balloon valvotomy is not available 
 A left atrial thrombus is present despite anticoagulation 
 A nonpliable or calcified valve with the decision to proceed with ei-
ther repair or replacement made at the time of the operation 
 Patients with moderate or severe mitral regurgitation should un-
dergo mitral valve replacement. 
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 The maze procedure may be useful to correct concomitant atrial fibril-
lation in patients undergoing valve replacement or surgical commissurotomy. 
 Inpatient & Outpatient Medications 
Medications cannot correct mitral stenosis, rather therapies are directed 
at reducing the incidence and severity of symptoms and complications. 
 Drugs that increase diastolic filling time and decrease the heart rate are 
typically used.  
 Beta-blockers are frequently used in this situation 
 Calcium channel blockers, such as diltiazem, and digoxin may also 
be used. Beta-blockers are preferred over digoxin because they control exer-
cise-induced increases in heart rate. 
 Rhythm control is of questionable clinical significance. Amiodarone 
may be used to maintain sinus rhythm, but its use may cause complications. 
 Anticoagulation is used in patients with atrial thrombi, in patients with 
atrial fibrillation, or in patients with a prior thromboembolic event. 
Deterrence/Prevention 
 Primary prophylaxis consists of an early diagnosis of group A streptococcal 
pharyngitis. Treatment started within 7-9 days after onset of illness may prevent rheumatic 
fever. Treatment with penicillin or if allergic (a macrolide) is recommended. To date, no 
strains of streptococci that produce rheumatic fever have been penicillin resistant. 
 The prevention of repeated attacks may delay the progression of mitral 
stenosis. Secondary prophylaxis may be individually tailored.  
 With carditis, secondary prevention continues for 10 years or until 
age 25 years. 
 Without carditis, secondary prevention continues for 5 years or un-
til age 18 years. 
 Endocarditis prophylaxis for routine dental and respiratory procedures 
is no longer recommended for patients with mitral stenosis unless they have 
had implantation of an artificial valve. 
Complication 
 Thromboembolism. 
 Atrial fibrillation. 
 Bacterial endocarditis. 
 Pulmonary hypertension. 
 Pulmonary edema. 
 Complications of balloon valvulotomy (eg, stroke, cardiac perforation, 
development of mitral regurgitation). 
 Complications of mitral valve replacement (eg, paravalvular leakage, 
thromboembolism, infective endocarditis, mechanical dysfunction, bleeding 
due to anticoagulants). 
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Prognosis 
 Depending on severity of symptoms of mitral stenosis (by the NYHA 
functional class), the 10-year survival rate is as follows:  
 85% for no symptom (class I). 
 34-42% for mild symptoms (early class II). 
 40% for moderate-severe symptoms (late class II, class III). 
 0% for class IV (Of class IV patients, survival is 42% at 1 year and 
10% at 5 years.). 
 The operative mortality rate is 1-2% for mitral commissurotomy and 
2-5% for mitral valve replacement. 
Mitral Regurgitation. Mitral regurgitation (MR) is incompetency 
of the mitral valve causing flow from the left ventricle (LV) into the left 
atrium during systole. Common causes include mitral valve prolapse, 
ischemic papillary muscle dysfunction, rheumatic fever, and annular dila-
tion secondary to LV systolic dysfunction and dilation. Complications in-
clude progressive heart failure, arrhythmias, and endocarditis. Symptoms 
and signs include palpitations, dyspnea, and a holosystolic apical murmur. 
Diagnosis is by physical examination and echocardiography. Prognosis 
depends on LV function and severity and duration of MR. Patients with 
mild, asymptomatic MR may be monitored, but progressive or symptomatic 
MR requires mitral valve repair or replacement.  
Etiology. MR may be acute or chronic. Causes of acute MR include 
ischemic papillary muscle dysfunction or rupture; infective endocarditis; acute 
rheumatic fever; spontaneous, traumatic, or ischemic tears or rupture of the 
mitral valve leaflets or subvalvular apparatus; acute dilation of the LV due to 
myocarditis or ischemia; and mechanical failure of a prosthetic mitral valve. 
Common causes of chronic MR include those of acute MR plus 
myxomatous degeneration of the mitral leaflets or chordae tendineae, mitral 
valve prolapse (MVP), mitral annular enlargement, and nonischemic papillary 
muscle dysfunction (eg, due to LV enlargement). Uncommon causes of chronic 
MR include a congenital endocardial cushion defect with a cleft anterior leaflet, 
SLE, acromegaly, myxoma involving the valve or chordae, and calcification of 
the mitral annulus (mainly in elderly women). 
Symptoms and Signs. Acute MR causes the same symptoms and signs 
as acute heart failure and cardiogenic shock  Most patients with chronic MR are 
initially asymptomatic and develop symptoms insidiously as the LA enlarges, 
pulmonary artery and venous pressure increases, and LV remodeling occurs. 
Symptoms include dyspnea, fatigue (due to heart failure), orthopnea, and palpi-
tations (often due to AF). Rarely, patients present with endocarditis (eg, fever, 
weight loss, embolic phenomena). 
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Signs develop only when MR becomes moderate to severe. Inspection 
and palpation may detect a brisk apical impulse and sustained left parasternal 
movement due to systolic expansion of an enlarged LA. An LV impulse that is 
sustained, enlarged, and displaced downward and to the left suggests LV hyper-
trophy and dilation. A diffuse precordial lift occurs with severe MR because the 
LA enlarges, causing anterior cardiac displacement, and pulmonary hyperten-
sion causes right ventricular hypertrophy. A regurgitant murmur (or thrill) may 
also be palpable in severe cases. 
 On auscultation, the 1st heart sound (S1) may be soft (or occasionally loud). 
A 3rd heart sound (S3) at the apex reflects a dilated LV and important MR. 
The cardinal sign of MR is a holosystolic (pansystolic) murmur, heard 
best at the apex with the diaphragm of the stethoscope when the patient is in the 
left lateral decubitus position. In mild MR, the systolic murmur may be abbre-
viated or occur late in systole. The murmur begins with S1 in conditions caus-
ing leaflet incompetency throughout systole, but it often begins after S1 (eg, 
when chamber dilation during systole distorts the valve apparatus or when 
myocardial ischemia or fibrosis alters dynamics). When the murmur begins 
after S1, it always continues to the 2nd heart sound (S2). The murmur radiates 
toward the left axilla; intensity may remain the same or vary. If intensity varies, 
the murmur tends to crescendo in volume up to S2. MR murmurs increase in 
intensity with handgrip or squatting because peripheral vascular resistance to 
ventricular ejection increases, augmenting regurgitation into the LA; murmurs 
decrease in intensity 
 with standing or the Valsalva maneuver. A short rumbling mid-
diastolic inflow murmur due to torrential mitral diastolic flow may be heard 
following an S3 . In patients with posterior leaflet prolapse, the murmur may be 
coarse and radiate to the upper sternum, mimicking aortic stenosis. MR mur-
murs may be confused with tricuspid regurgitation, which can be distinguished 
because its murmur is augmented during inspiration. 
Diagnosis 
 Echocardiography 
Diagnosis is suspected clinically and confirmed by echocardiography. 
Doppler echocardiography is used to detect regurgitant flow and help quantify 
its severity; 2-dimensional echocardiography is used to determine the cause of 
MR and to detect pulmonary hypertension. 
If endocarditis or valvular thrombi are suspected, transesophageal echo-
cardiography (TEE) can provide a more detailed view of the mitral valve and 
LA. TEE is also indicated when mitral valve repair instead of replacement is 
being considered to confirm the anatomy in more detail. 
An ECG and chest x-ray are usually obtained initially.  
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 ECG may show LA enlargement and LV hypertrophy with or without 
ischemia. Sinus rhythm is usually present when MR is acute because the atria 
have not had time to stretch and remodel. 
 Chest x-ray in acute MR may show pulmonary edema; abnormalities 
in cardiac silhouette are not evident unless an underlying chronic disorder is 
also present. Chest x-ray in chronic MR may show LA and LV enlargement. It 
may also show pulmonary vascular congestion and pulmonary edema with 
heart failure. 
Cardiac catheterization is done before surgery, mainly to determine 
whether coronary artery disease (CAD) is present. A prominent systolic c-v 
wave is seen on pulmonary artery occlusion pressure (pulmonary capillary 
wedge pressure) tracings during ventricular systole. Ventriculography can be 
used to quantify MR. 
Differential diagnosis 
1. Ventricular septal defect  
2. Aortic valve disease—The ejection systolic murmur of aortic valve 
disease is frequently audible at the apex, where it may be louder than at the 
base, and have a slightly different quality. However, this is not an adequate 
basis for diagnosing additional mitral regurgitation and it is essential to estab-
lish that the timing of the murmur is pansystolic, either from its relation to the 
second heart sound, or in aortic regurgitation, from its relation to the start of the 
early diastolic murmur. 
3. Tricuspid regurgitation—The pansystolic murmur of tricuspid regur-
gitation may be mistaken for that of mitral regurgitation, particularly when the 
right ventricle is greatly enlarged. The presence of tricuspid regurgitation can 
be suspected from an elevated venous pressure with systolic waves, and con-
firmed by Doppler echocardiography. In severe mitral regurgitation, however, 
additional tricuspid regurgitation may be present. 
Prognosis. Prognosis varies by acuity and cause of MR. Once MR be-
comes severe, about 10% of asymptomatic patients become symptomatic per 
year thereafter. About 10% of patients with chronic MR caused by MVP re-
quire surgical intervention. 
Treatment 
 Mitral valve repair or replacement 
Acute MR requires emergency mitral valve repair or replacement; pa-
tients with ischemic papillary muscle rupture may also require coronary revas-
cularization. Pending surgery, nitroprusside or nitroglycerin infusion may be 
used to reduce afterload, thus improving forward stroke volume and reducing 
ventricular and regurgitant volume. 
Definitive treatment of chronic MR is also mitral valve repair or re-
placement, but patients with asymptomatic or mild chronic MR and no pulmo-
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nary hypertension or AF may do well with periodic monitoring. ACE inhibitors 
or angiotensin receptor blockers are used to decrease left ventricular preload 
and afterload. They are used in patients with moderate mitral insufficiency to 
delay dilation of the LV. Loop diuretics such as furosemide are helpful in pa-
tients with exertional or nocturnal dyspnea. Digoxin may reduce symptoms in 
patients with atrial fibrillation or those in whom valve surgery is not appropri-
ate. The ideal timing for surgery is uncertain, but intervention before ventricu-
lar decompensation (defined as echocardiographic end-diastolic dimension > 70 
mm, end-systolic dimension > 45 mm, and ejection fraction < 60%) improves 
outcomes and decreases the chance of worsening LV function. After decompensation, 
ventricular function becomes dependent on the afterload reduction of MR, and in 
about 50% of decompensated patients, valve replacement causes a markedly de-
pressed ejection fraction. For patients with moderate MR and significant CAD, pe-
rioperative mortality rate is 1.5% with bypass surgery alone and 25% with concomi-
tant valve replacement. If technically feasible, valve repair instead of replacement is 
preferred; perioperative mortality rate is 2 to 4% (compared with 5 to 10% for re-
placement), and long-term prognosis is good (80 to 94% survival rate at 5 to 10 yr, 
compared with 40 to 60% for replacement). 
Antibiotic prophylaxis is no longer recommended except for patients 
who have had valve replacement . Anticoagulants are used to prevent throm-
boemboli in patients with heart failure or AF. Although severe MR without 
mitral stenosis or AF is less likely to be complicated by atrial thrombosis, most 
cardiologists still recommend anticoagulants. 
Mitral valve prolapse (MVP). Mitral valve prolapse (MVP) is a bil-
lowing of mitral valve leaflets into the left atrium during systole.  
The most common cause is idiopathic myxomatous degeneration. MVP 
is usually benign, but  
complications include mitral regurgitation, endocarditis, valve rupture, 
and possibly thromboembolism. 
 MVP is usually asymptomatic, in the absence of important regurgita-
tion, although there are reports that some patients experience chest pain, dysp-
nea, dizziness, and palpitations. Signs include a crisp mid-systolic click, fol-
lowed by a late systolic murmur if regurgitation is present. Diagnosis is by 
physical examination and echocardiography. Prognosis is excellent in the ab-
sence of significant regurgitation, but chordal rupture and endocarditis may 
occur. No specific treatment is necessary unless mitral regurgitation is present.  
MVP is common; prevalence is 1 to 3% in otherwise normal popula-
tions, depending on the echocardiographic criteria used. Women and men are 
affected equally; onset usually follows the adolescent growth spurt. 
Symptoms and Signs. Most patients are asymptomatic. Some experi-
ence nonspecific symptoms (eg, chest pain, dyspnea, palpitations, dizziness, 
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near syncope, migraines, anxiety), thought to be due to poorly defined associ-
ated abnormalities in adrenergic signaling and sensitivity rather than to mitral 
valve pathology.  
In about one third of patients, emotional stress precipitates palpitations, which 
may be a symptom ofbenign arrhythmias (atrial premature beats, paroxysmal atrial 
tachycardia, ventricular premature beats, complex ventricular ectopy). 
Occasionally, patients present with MR. Rarely, patients present with 
endocarditis (eg, fever, weight loss, thromboembolic phenomena) or stroke. 
Sudden death occurs in < 1%, most often resulting from ruptured chordae 
tendineae and flail mitral valve leaflets. Death due to a fatal arrhythmia is rare. 
Typically, MVP causes no visible or palpable cardiac signs. MVP alone 
causes a crisp mid-systolic click heard best with the diaphragm of the stetho-
scope over the left apex when the patient is in the left lateral decubitus position. 
MVP with MR causes a click with a late-systolic MR murmur. The click be-
comes audible or moves closer to the 1st heart sound (S1) and becomes louder 
with maneuvers that decrease left ventricle (LV) size (eg, sitting, standing, 
Valsalva maneuver); the same maneuvers cause an MR murmur to appear or 
become louder and last longer. These effects occur because decreasing LV size 
causes papillary muscles and chordae tendineae to pull together more centrally 
beneath the valve, resulting in quicker, more forceful prolapse with earlier, 
more severe regurgitation. Conversely, squatting or isometric handgrip delays 
the S1 click and shortens the MR murmur. The systolic click may be confused 
with the click of congenital aortic stenosis, which can be distinguished because 
it occurs very early in systole and does not move with postural or LV volume 
changes. Other findings include a systolic honk or whoop, thought to be caused 
by valvular leaflet vibration; these findings are usually transient and may vary 
with respiratory phase. An early diastolic opening snap caused by return of the 
prolapsed valve to its normal position is rarely heard. 
Diagnosis 
Echocardiography. Diagnosis is suggested clinically and confirmed by 
2-dimensional echocardiography. Holosystolic displacement of ≥ 3 mm or late 
systolic displacement of ≥ 2 mm identifies 95% of patients with MVP; the 
percentage is slightly higher if echocardiography is done while the patient is 
standing. Thickened, redundant mitral valve leaflets and displacement of ≥ 5 
mm are thought to indicate more extensive myxomatous degeneration and 
greater risk of endocarditis and MR.Holter monitoring and 12-lead ECG may 
be useful for documenting arrhythmias in patients with palpitations. 
Prognosis. MVP is usually benign, but severe myxomatous degenera-
tion of the valve can lead to MR. In patients with severe MR, incidence of LV 
or left atrium enlargement, arrhythmias (eg, AF), infective endocarditis, stroke, 
need for valve replacement, and death is about 2 to 4%/yr. 
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Treatment 
 Usually none 
 Sometimes β-blockers 
Treatment of MR depends on severity and associated left atrial and LV 
changes. 
Antibiotic prophylaxis against endocarditis is no longer recommended. 
Anticoagulants to prevent thromboembolism are recommended only for pa-
tients with AF or prior transient ischemic attack or  
stroke. 
Aortic stenosis (AS). Aortic stenosis (AS) is narrowing of the aortic 
valve obstructing blood flow from the left ventricle to the ascending aorta dur-
ing systole.  
The aortic valve area must be reduced to one fourth its normal size be-
fore significant changes in the circulation occur. Because the normal adult valve 
orifice is 3.0 to 4.0 cm2, an area 0.75 to 1.0 cm2 is usually not considered 
severe AS. In large patients, a valve area of 1.0 cm2 may be severely stenotic, 
whereas a valve area of 0.7 cm2 may be adequate for a smaller patient.  
The committee used a variety of hemodynamic and natural history data to 
grade the degree of AS as mild (area >1.5 cm2), moderate (area >1.0 to 1.5 cm2), or 
severe (area 1.0cm2). When stenosis is severe and cardiac output is normal, the mean 
transvalvular pressure gradient is generally >50 mm Hg. Some patients with severe 
AS remain asymptomatic, whereas others with only moderate stenosis develop symp-
toms. Therapeutic decisions, particularly those related to corrective surgery, are based 
largely on the presence or absence of symptoms. Thus, the absolute valve area (or 
transvalvular pressure gradient) is not usually the primary determinant of the need for 
aortic valve replacement (AVR).  
Causes  
 congenital bicuspid valve,  
 idiopathic degenerative sclerosis with calcification,  
 rheumatic fever.  
Symptoms and Signs.Congenital AS is usually asymptomatic until at 
least age 10 or 20 yr, when symptoms may begin to develop insidiously. In all 
forms, progressive untreated AS ultimately results in exertional syncope, an-
gina, and dyspnea (SAD triad). Other symptoms and signs may include those of 
HF and arrhythmias, including ventricular fibrillation leading to sudden death. 
Physical 
 The most common signs of aortic stenosis include a pulse of small 
amplitude. 
 Palpation reveals a laterally displaced apex reflecting the presence of 
left ventricular hypertrophy. 
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 A systolic thrill may be palpable at the base of the heart, in the jugular 
notch, and along the carotid arteries. 
Crescendo-decrescendo systolic ejection murmur begins shortly after 
the first heart sound. The intensity increases toward midsystole, then decreases, 
and the murmur ends just before the second heart sound. It is generally a rough, 
low-pitched sound that is loudest at the base of the heart and most commonly is 
 Appreciated in the second right intercostal space that radiates to the 
carotids.  An ejection click may be auscultated. This is associated with bicuspid 
valves. 
 An audible fourth heart sound indicates the presence of left ventricular 
hypertrophy in severe aortic stenosis. Once the left ventricle dilates and fails, a 
third heart sound may be audible. 
 Pulsus parvus et tardus: This is an arterial pulse with a delayed and 
plateaued peak, decreased amplitude, and gradual downslope. 
 A high-pitched, diastolic blowing murmur may be present if the pa-
tient has associated aortic regurgitation. 
Diagnosis 
 Echocardiography 
Diagnosis is suspected clinically and confirmed by echocardiography. Two-
dimensional transthoracic echocardiography is used to identify a stenotic aortic valve 
and possible causes, to quantify LV hypertrophy and degree of diastolic or systolic 
dysfunction, and to detect  coexisting valvular heart disorders (aortic regurgitation, 
mitral valve disorders) and complications (eg, endocarditis). Doppler echocardiogra-
phy is used to quantify degree of  stenosis by measuring aortic valve area, jet velocity, 
and transvalvular systolic pressure gradient. 
A valve area of 0.5 to 1.0 cm2 or a mean gradient > 45 to 50 mm Hg 
represents severe stenosis. The gradient may be overestimated in aortic regurgi-
tation and underestimated in LV systolic dysfunction. The rate of progression 
of AS from mild to severe is quite variable and does not necessarily proceed in 
a linear fashion. 
Cardiac catheterization is necessary to determine whether coronary ar-
tery disease (CAD) is the cause of angina and, occasionally, to resolve differ-
ences between clinical and echocardiographic findings. 
 ECG  typically shows changes of LV hypertrophy with or without an 
ischemic ST- and T-wave pattern.  
 Chest x-ray findings may include calcification of the aortic cusps 
(seen on the lateral projection or on fluoroscopy) and evidence of HF. Heart 
size may be normal or only mildly enlarged. 
Differential diagnosis 
1. Hypertrophic cardiomyopathy—This can present with a history very 
similar to that  of aortic stenosis. By contrast, the carotid pulse is normal or jerky 
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rather than slow rising. The diagnosis is confirmed by echocardiography, which re-
veals a normal aortic valve and shows characteristic ventricular features.  
2. Congestive cardiomyopathy—Patients with long-standing untreated 
aortic stenosis can present with severe breathlessness, a large heart on radiog-
raphy, a small volume pulse with a normal upstroke, a third heart sound, 
and pansystolic murmur due to papillary muscle dysfunction. These fea-
tures can all be found in congestive cardiomyopathy In endstage aortic stenosis, 
the echocardiogram shows a calcified valve with a significant (more than 35 
mmHg) pressure drop across it: in congestive cardiomyopathy it shows a di-
lated and poorly  contractile ventricle, but the aortic valve is normal. 
3. Fixed subaortic stenosis—This is usually discovered in asympto-
matic children and young adults in whom a systolic murmur is detected on 
routine examination. 
An ejection click is absent, and a short early diastolic murmur usually 
heard. There is clinical and ECG evidence of left ventricular disease, which 
may be severe. The two-dimensional echocardiogram usually demonstrates the 
site and type of obstruction. 
Prognosis. AS may progress slowly or quickly and thus requires regular 
follow-up to detect progression, particularly in sedentary elderly patients. In 
such patients, flow may become significantly compromised without triggering 
symptoms. 
Overall, about 3 to 6% of asymptomatic patients with normal sys-
tolic function develop symptoms or LV ejection fraction depression every 
year. However, surgery is usually delayed until symptoms develop because 
the risk of surgery outweighs the survival benefit in asymptomatic patients. 
Surgery should not be delayed once symptoms develop. Mean survival in 
untreated symptomatic patients is about 2 to 3 yr. Aortic valve replacement 
relieves symptoms and improves survival. Risk with surgery increases for 
patients who require simultaneous coronary artery bypass graft (CABG) and 
for those with depressed systolic LV function. About 50% of deaths occur 
suddenly. While awaiting surgery, patients with severe AS should be ad-
vised to restrict physical exertion. 
Treatment 
 Aortic valve replacement 
 Balloon valvuloplasty 
Medical. Generally, any medical therapy has relatively poor effect in 
treating aortic stenosis.  It is useful, however, in management of concomitant 
conditions that correlate with aortic stenosis: 
 Any angina is generally treated with short-acting nitrovasodilators, 
beta-blockers and/or calcium blockers. 
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 Any hypertension is treated aggressively, but caution must be taken in 
administering beta-blockers. 
Any heart failure is generally treated with digoxin, diuretics, 
nitrovasodilators and if not contraindicated, cautious inpatient administration 
of ACE inhibitors. 
Since calcific aortic stenosis shares many pathological features and risk 
factors with atherosclerosis, and since atherosclerosis may be prevented and/or 
reversed by cholesterol lowering, there has been interest in attempting to mod-
ify the course of calcific aortic stenosis by cholesterol lowering with statin 
drugs. Although a number of small, observational studies demonstrated an 
association between lowered cholesterol and decreased progression, and even 
regression, of calcific aortic stenosis. 
Aortic regurgitation. Aortic regurgitation (AR), is the leaking of the 
aortic valve of the heart that causes blood to flow in the reverse direction dur-
ing ventricular diastole, from the aorta into the left ventricle. 
Etiology 
 Acute aortic regurgitation.  
 Rheumatic. 
 Infective endocarditis. 
 Ruptured sinus of Valsalva. 
 Trauma, prosthetic valve surgery. 
 Aortic dissection, laceration of the aorta. 
 Chronic aortic regurgitation.  
 Rheumatic. 
 Syphilis. 
 Aortitis (ie, Takayasu disease). 
 Marfan syndrome. 
 Osteogenesis imperfecta. 
 Bicuspid aortic valve, defect of the interventricular septum or sinus 
of Valsalva. 
 Ankylosing spondylitis. 
 Reiter syndrome. 
 Rheumatoid arthritis. 
 Systemic lupus erythematosus. 
 Hypertension. 
 Infective endocarditis. 
Clinical features 
Symptoms. Patients with aortic regurgitation remain asymptomatic for 
many years. When symptoms develop, they are those of left ventricular disease, 
with:  
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 limitation of exercise tolerance by breathlessness or chest pain the 
most prominent one. Less commonly,  
 the presenting symptom may be nocturnal dyspnoea, or an attack of 
acute pulmonary oedema.  
 Retrosternal pain, aggravated by exertion, may develop in patients 
with aneurysms of the ascending aorta in whom the coronary arteries are nor-
mal. This seems to originate from the aortic root itself. Aortic dissection  may 
also cause severe central chest pain. 
Physical signs 
 The hallmark of aortic regurgitation/insufficiency is a high-pitched de-
crescendo diastolic murmur at the left sternal border after the second heart 
sound. 
 Acute aortic regurgitation  
 Patients who have CHF or shock associated with severe aortic re-
gurgitation often appear gravely ill. 
 Tachycardia. 
 Peripheral vasoconstriction. 
 Cyanosis. 
 Pulmonary edema. 
 Arterial pulsus alternans; normal left ventricular impulse. 
 Early diastolic murmur (lower pitched and shorter than in chronic 
aortic regurgitation) may be present. An Austin-Flint murmur, which is caused 
by the regurgitant flow causing vibration of the mitral apparatus, is lower 
pitched and short in duration. The decrescendo diastolic murmur is heard best 
with the patient leaning forward in full expiration in a quiet room. It is the car-
diac murmur most commonly missed. 
 A murmur at the right sternal border is associated more often with 
dissection than any other cause of aortic regurgitation. 
 Chronic aortic regurgitation.  
 All auscultatory phenomena indicate vasodilatation of peripheral 
circulation. 
 Hyperdynamic apical impulse displaced laterally and inferiorly 
may be associated with an ejection click. 
 Decrescendo diastolic murmur is heard best while the patient is 
leaning forward on deep expiration. 
 Apical middiastolic rumble. 
 Austin-Flint murmur. 
 Pulsus bisferiens; increased pulse pressure; visible, forceful, and 
bounding peripheral pulses (water hammer). 
 Corrigan pulse - Quickly collapsing pulses. Visible arterial pulsa-
tion in the neck. 
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 Musset sign - Bobbing of the head. 
 Quincke sign - Capillary pulsations of the nail bed. 
 Muller sign - Pulsations of the uvula. 
 Hill sign - Systolic pressure in lower extremity greater than systolic 
pressure in upper extremity by at least 100 mm Hg. 
 Traube sign - Loud systolic sound over femoral arteries. 
 Duroziez sign - Systolic-diastolic murmur produced by compres-
sion of femoral artery with a stethoscope. 
Investigations 
 transthoracic echocardiography, which can provide two-
dimensional views of the regurgitant jet, allow measurement of velocity using 
Doppler, and estimate jet volume. 
The findings in severe aortic regurgitation, based on the 2006 American 
College of Cardiology/American Heart Association guidelines include: 
 An AI color jet width > 65 percent of the left ventricular outflow tract 
(LVOT) diameter (may not be true if the jet is eccentric) 
 Doppler vena contracta width > 0.6cm 
 The pressure half-time of the regurgitant jet is < 250 msec 
 Early termination of the mitral inflow (due to increase in LV pressure 
due to the AI.) 
 Holodiastolic flow reversal in the descending aorta. 
 Regurgitant volume > 60 ml 
 Regurgitant fraction > 50 percent 
 Regurgitant orifice area > 0.3 cm2 
 Increased left ventricular size 
In acute aortic regurgitation, echocardiography may show early closure 
of the mitral valve.  
 Chest X-ray can assist in making the diagnosis, showing left ventricu-
lar hypertrophy and dilated aorta.  
 ECG  typically indicates left ventricular hypertrophy.  
 Cardiac chamber catetherization assists in assessing the severity of 
regurgitation and any left ventricular dysfunction.  
Differential diagnosis 
Aortic regurgitation should also be distinguished from other causes of 
aortic run-off: 
1. persistent ductus arteriosus; 
2. ruptured sinus of Valsalva aneurysm; and 
3. coronary arteriovenous fistula. 
Treatment. Aortic insufficiency can be treated either medically or surgi-
cally, depending on the acuteness of presentation, the symptoms and signs associ-
ated with the disease process, and the degree of left ventricular dysfunction. 
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Surgical treatment is controversial in asymptomatic patients, however 
has been recommended if the ejection fraction falls to 50% or below, in the face 
of progressive and severe left ventricular dilatation, or with symptoms or ab-
normal response to exercise testing. For both groups of patients, surgery before 
the development of worsening ejection fraction/LV dilatation, is expected to 
reduce the risk of sudden death, and is associated with lower peri-operative 
mortality. Also, surgery is optimally performed immediately in acute cases. 
Medical treatment. Medical therapy of chronic aortic insufficiency that 
is stable and asymptomatic involves the use of vasodilators. Small trials have 
shown a short term benefit in the use of ACE inhibitors or angiotensin II re-
ceptor antagonists, nifedipine, and hydralazine in improving left ventricular 
wall stress, ejection fraction, and mass. The use of these vasodilators is only 
indicated in individuals who suffer from hypertension in addition to AI. The 
goal in using these pharmacologic agents is to decrease the afterload so that the 
left ventricle is somewhat spared. The regurgitant fraction may not change 
significantly, since the gradient between the aortic and left ventricular pressures 
is usually fairly low at the initiation of treatment. 
Other rather conservative medical treatments for stable and asympto-
matic cases include low sodium diet, diuretics, digoxin, calcium blockers and 
avoiding very strenous activity. 
In additon, endocarditis prophylaxis is indicated before dental, 
gastrointestinal or genitourinary procedures.  
In mild to moderate cases, echocardiography and cardiac stress test 
should be followed up every 1-2 years. In severe moderate/severe cases, echo-
cardiography with cardiac stress test and/or isotope perfusion imaging should 
be performed every 3-6 months.  
Surgical treatment. The surgical treatment of choice at this time is an 
aortic valve replacement. This is currently an open-heart procedure, requiring 
the individual to be placed on cardiopulmonary bypass. 
Tricuspid regurgitation (TR).Tricuspid regurgitation (TR) is insuffi-
ciency of the tricuspid valve causing blood flow from the right ventricle to the 
right atrium during systole. The most common cause is dilation of the right 
ventricle. Symptoms and signs are usually absent, but severe TR can cause 
neck pulsations, a holosystolic murmur, and right ventricular–induced heart 
failure or atrial fibrillation. Diagnosis is by physical examination and echocar-
diography. TR is usually benign and does not require treatment, but some pa-
tients require annuloplasty or valve repair or replacement.  
Etiology. TR is most commonly caused by dilation of the right ventricle 
(RV) with malfunction of a normal valve, as occurs in pulmonary hypertension, 
RV dysfunction–induced heart failure (HF), and pulmonary outflow tract ob-
struction. TR results less commonly from infective endocarditis in IV drug 
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abusers, carcinoid syndrome, chest or abdominal injury, rheumatic fever, idio-
pathic myxomatous degeneration, ischemic papillary muscle dysfunction, con-
genital defects (eg, cleft tricuspid valve, endocardial cushion defects), Ebstein's 
anomaly (downward displacement of a distorted tricuspid cusp into the RV), 
Marfan syndrome, and use of certain drugs (eg, ergotamine, fenfluramine, 
phentermine Long-standing severe TR may lead to RV dysfunction–induced 
HF and atrial fibrillation (AF). 
Symptoms and Signs. TR usually causes no symptoms, but some pa-
tients experience neck pulsations due to elevated jugular pressures. Acute or 
severe TR may cause symptoms of RV dysfunction–induced HF. Patients may 
also develop symptoms of AF or atrial flutter. 
Pedal edema or ascites can occur in severe TR. 
The only visible sign of moderate to severe TR is jugular venous disten-
tion, with a prominent merged c-v wave and a steep y descent. In severe TR, a 
right jugular venous thrill may be palpable, as may systolic hepatic pulsation 
and an RV impulse at the left lower sternal border. On auscultation, the 1st 
heart sound (S1) may be normal or barely audible if a TR murmur is present; 
the 2nd heart sound (S2) may be split (with a loud pulmonic component [P2] in 
pulmonary hypertension) or single because of prompt pulmonic valve closing 
with merger of P2 and the aortic component (A2). An RV 3rd heart sound (S3) 
may be audible near the sternum with RV dysfunction–induced HF. 
The murmur of TR is a holosystolic murmur heard best at the left 
middle or lower sternal border or at the epigastrium with the bell of the 
stethoscope when the patient is sitting upright or standing. The murmur 
may be high-pitched if TR is trivial and due to pulmonary hypertension, or 
it may be medium-pitched if TR is severe and has other causes. Sometimes 
the murmur is not present at all and the diagnosis is best made by the ap-
pearance of the jugular venous wave pattern and the presence of hepatic 
systolic pulsations. The murmur varies with respiration, becoming louder 
with inspiration (Carvallo's sign). 
Diagnosis 
 Echocardiography 
Mild TR is most often detected on echocardiography done for other rea-
sons. More moderate or severe TR may be suggested by history and physical 
examination and confirmed by Doppler echocardiography. An ECG and chest 
x-ray are also often obtained.  
 ECG is usually normal but, in advanced cases, may show tall peaked P 
waves caused by right atrial enlargement, a tall R or QR wave in V1 character-
istic of RV hypertrophy, or AF.  
 Chest x-ray is usually normal but, in advanced cases with RV hyper-
trophy or RV dysfunction–induced HF, may show an enlarged superior vena 
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cava, an enlarged right atrial or RV silhouette (behind the upper sternum in the 
lateral projection), or pleural effusion. 
Cardiac catheterization is rarely indicated for evaluation of TR. When 
catheterization is indicated (eg, to evaluate coronary anatomy), findings include 
a prominent right atrial c-v wave during ventricular systole. 
Prognosis. Few reliable data about prognosis exist because so few pa-
tients develop severe TR in isolation. 
Treatment 
 Treatment of cause 
 Sometimes valve repair or replacement 
TR is usually well tolerated and often does not require surgical treat-
ment. Medical treatment of causes (eg, HF, endocarditis) is indicated. The tri-
cuspid valve may be repaired during surgery for left-sided heart lesions, such as 
mitral stenosis or regurgitation. Surgery may also be indicated for TR alone 
when RV impairment or hepatic cirrhosis threatens. 
If endocarditis has damaged the tricuspid valve and cannot be cured 
with antibiotics, the valve may be totally excised and not replaced until 6 to 9 
mo later; this procedure is well tolerated. 
Tricuspid stenosis (TS). Tricuspid stenosis (TS) is narrowing of the 
tricuspid orifice that obstructs blood flow from the right atrium to the right 
ventricle. Almost all cases result from rheumatic fever. Symptoms include a 
fluttering discomfort in the neck, fatigue, cold skin, and right upper quadrant 
abdominal discomfort. Jugular pulsations are prominent, and a presystolic 
murmur is often heard at the left sternal edge in the 4th intercostal space and is 
increased during inspiration. Diagnosis is by echocardiography. TS is usually 
benign, requiring no specific treatment, but symptomatic patients may benefit 
from surgery.  
TS is almost always due to rheumatic fever; tricuspid regurgitation is 
almost always also present, as is a mitral valve disorder (usually mitral steno-
sis). Rare causes of TS include SLE, right atrial (RA) myxoma, congenital 
malformations, and metastatic tumors. The RA becomes hypertrophied and 
distended, and sequelae of right heart disease–induced heart failure develop but 
without right ventricular (RV) dysfunction; the RV remains underfilled and 
small. Uncommonly, atrial fibrillation occurs. 
Symptoms and Signs. The only symptoms of severe TS are fluttering 
discomfort in the neck (due to giant a waves in the jugular pulse), fatigue and 
cold skin (due to low cardiac output), and right upper quadrant abdominal dis-
comfort (due to an enlarged liver). 
The primary visible sign is a giant flickering a wave with gradual y de-
scent in the jugular veins. Jugular venous distention may occur, increasing with 
inspiration (Kussmaul's sign). The face may become dusky and scalp veins may 
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dilate when the patient is recumbent (suffusion sign). Hepatic congestion and 
peripheral edema may occur. 
On auscultation, TS may produce a soft opening snap and a mid-
diastolic rumble with presystolic accentuation. The murmur becomes louder 
and longer with maneuvers that increase venous return (exercise, inspiration, 
leg-raising, Müller's maneuver) and softer and shorter with maneuvers that 
decrease venous return (standing, Valsalva maneuver). 
Diagnosis 
 Echocardiography 
Diagnosis is suspected based on history and physical examination and 
confirmed by Doppler echocardiography showing a pressure gradient across the 
tricuspid valve. Two-dimensional echocardiography shows thickened leaflets 
with reduced movement and RA enlargement.  
 ECG may show RA enlargement out of proportion to RV hypertrophy 
and tall, peaked P waves in inferior leads and V1.  
 Chest x-ray may show a dilated superior vena cava and RA enlarge-
ment, indicated by an enlarged right heart border. Liver enzymes are elevated 
because of passive hepatic congestion. 
 Cardiac catheterization is rarely indicated for evaluation of TS. 
When catheterization is indicated (eg, to evaluate coronary anatomy), findings 
include elevated RA pressure with a slow fall in early diastole and a diastolic 
pressure gradient across the tricuspid valve. 
Treatment 
 Diuretics and aldosterone antagonists 
 Rarely valve repair or replacement 
Evidence to guide treatment is scarce. For all symptomatic pa-
tients, treatment should include a low-salt diet, diuretics, and aldosterone 
antagonists. Patients with hepatic congestion leading to cirrhosis or severe 
systemic venous congestion and effort limitation may benefit from inter-
ventions such as balloon valvotomy or valve repair or replacement. Com-
parative outcomes are unstudied. 
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6. TESTS AND ASSIGNMENTS FOR SELF-ASSESSMENT  
FINAL LEVEL OF KNOWLEDGES 
 
1. A 45-year-old woman has had worsening shortness of breath for 3 
years. She now has to sleep sitting up on two pillows. She has had difficulty 
swallowing for the past year. She has no history of chest pain. She is afebrile. 
On physical examination palpation of the carotid arteries reveals a hypokinetic 
pulse. Palpation of the precordium reveals a right ventricular heave and the 
absence of the left ventricular impulse. Auscultatory findings include a loud S1, 
most prominent is an early diastolic opening snap and decrescendo-crescendo 
rumbling diastolic murmur, heard best at the apex. A chest radiograph reveals a 
near-normal left ventricular size with a prominent left atrial border.  An echo-
cardiogram shows decreased opening of the mitral valve leaflets, and increased 
blood flow velocity during diastole. The trans-mitral gradient as measured by 
Doppler echocardiography is 10.Which of the following conditions is most 
likely to account for these findings? 
А. Mitral valve stenosis. 
В. Aortic coarctation. 
С. Left renal artery stenosis. 
D. Cardiomyopathy. 
Е. Essential hypertension. 
 
  
2. A patient presents to the cardiology clinic with a new onset pan-
systolic murmur after a recent ST elevation anterior MI. Physical examina-
tion reveals a woman in no apparent distress with a heart rate of 110 bpm, 
blood pressure of 95/50 mm Hg, jugular venous pressure of 10 cm above 
right atrium, and bibasilar rales. Extremities are cool with 1+ edema. The 
echocardiogram reveals a ventricular septal rupture with left-to-right shunt-
ing and no valvular or paravalvular leak. Which of the following interven-
tions has been associated with decreased mortality rates in stable patients 
with post-MI ventricular septal rupture?  
А. Early surgical closure.  
В. IABP.  
С. IV dopamine.  
D. IV fluid administration.  
Е. IV dopamine.  
F. IV fluid administration.  
G. IV nitroprusside.  
 
 
3. A 45-year-old man is admitted to the intensive care unit with symp-
toms of congestive heart failure. He is addicted to heroin and cocaine and uses 
both drugs daily via injection.His blood cultures have yielded methicillin-
sensitive Staphylococcus aureus in four of four bottles within 12 h. His vital 
signs show a blood pressure of 110/40 mmHg and a heart rate of 132 beats/min. 
There is a IV/VI diastolic murmur heard along the left sternal border. A sche-
matic representation of the carotid pulsation is shown in the figure below. What 
is the most likely cause of the patient’s murmur? 
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A. Aortic regurgitation. 
B. Aortic stenosis. 
C. Mitral stenosis. 
 
D. Mitral regurgitation. 
E. Tricuspid regurgitation. 
 
 
4. A 50-year-old man has had progressive exertional dyspnea and chest 
pain for the past 2 months. Palpation of the carotid arteries reveals a diminished 
and delayed pulse. Palpation of the precordium reveals a dilated, sustained 
apical or left ventricular impulse with a presystolic impulse. On physical ex-
amination auscultation of the chest reveals an easily heard systolic, crescendo-
decrescendo murmur is heard loudest at the upper right sternal border, and 
radiates to the carotid arteries bilaterally. An echocardiogram show a thickened, 
calcified aortic valve which opens poorly. Mean gradient on either side of the 
aortic valve is 50 mm Hg. 
What is the most likely cause of the patient’s condition? 
А. Aortic stenosis.  
В. Hypertrophic cardiomyopathy.  
С. Mitral stenosis.  
D. Pulmonic stenosis.  
Е. Ventricular fibrillation. 
 
 
5. A 72-year-old male comes to the office with intermittent symptoms 
of dyspnea on exertion, palpitations, and cough occasionally productive of 
blood. On cardiac auscultation, a low-pitched diastolic rumbling murmur is 
faintly heard toward the apex. The origin of the patient’s problem probably 
relates to 
A. Rheumatic fever as a youth. 
B.. Long-standing hypertension. 
 
C. Silent MI within the past year. 
D. Congenital origin. 
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